First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccinatio
Keywords: Affordable IPV; IPV dose sparing; Dose investigation; Aluminium hydroxide adjuvant;